Successful Use of Intravenous Immunoglobulin G to Treat Refractory Heparin-Induced Thrombocytopenia With Thrombosis Complicating Peripheral Blood Stem Cell Harvest

Heparin-induced thrombocytopenia is a well-known, life-threatening complication that occurs in 5% of patients exposed to heparin. It causes thrombocytopenia in roughly 85% to 90% of affected individuals, with expected recovery in approximately 4 to 10 days following heparin withdrawal. However, ther...

Descripción completa

Detalles Bibliográficos
Autores principales: McKenzie, Devon S., Anuforo, Josephine, Morgan, Jennah, Neculiseanu, Elvira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791472/
https://www.ncbi.nlm.nih.gov/pubmed/29404376
http://dx.doi.org/10.1177/2324709618755414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791472/
https://www.ncbi.nlm.nih.gov/pubmed/29404376
http://dx.doi.org/10.1177/2324709618755414

Ejemplares similares